Key Points
- Director Watkin Phoebe Yang bought 1,000 shares of GE HealthCare Technologies at an average price of $63.01, a transaction worth $63,010 and increasing their stake by 7.87%.
- GE HealthCare shares were down 2.8% and opened at $61.70, trading well below both the 50-day and 200-day moving averages.
- The company recently reported mixed quarterly results: EPS missed estimates at $0.99 versus $1.07 expected, while revenue came in above forecasts at $5.13 billion and rose 7.4% year over year.
GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) Director Watkin Phoebe Yang acquired 1,000 shares of the firm's stock in a transaction on Friday, May 8th. The shares were bought at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the acquisition, the director owned 13,702 shares in the company, valued at approximately $863,363.02. The trade was a 7.87% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
GE HealthCare Technologies Trading Down 2.8%
GEHC opened at $61.70 on Tuesday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The stock has a market capitalization of $28.07 billion, a PE ratio of 14.76, a PEG ratio of 1.43 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The firm has a 50-day moving average price of $71.06 and a two-hundred day moving average price of $77.15.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.35%.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company dropped their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an "overweight" rating for the company in a research report on Thursday, April 30th. BNP Paribas Exane decreased their price target on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. BTIG Research lowered their price objective on GE HealthCare Technologies from $85.00 to $80.00 and set a "buy" rating for the company in a research report on Wednesday, April 29th. Oppenheimer reissued an "outperform" rating and set a $85.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Finally, Jefferies Financial Group cut their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Eight research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of "Hold" and an average price target of $80.67.
Get Our Latest Research Report on GEHC
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies in the fourth quarter valued at about $26,000. Optima Capital LLC acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Godfrey Financial Associates Inc. acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Montag A & Associates Inc. increased its stake in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company's stock valued at $28,000 after acquiring an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock valued at $28,000 after acquiring an additional 262 shares during the period. 82.06% of the stock is currently owned by institutional investors.
GE HealthCare Technologies Company Profile
(
Get Free Report)
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
